Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation - Report - MDSpire

Adapting DeepLabV3+ for biopsy cervical cancer lesion segmentation

  • By

  • Rose Nakasi

  • Cosmas Wamozo

  • Solomon Nsumba

  • Benjamin Rukundo

  • Tonny Okecha

  • Byron Mubiru

  • Chodrine Mutebi

  • May 11, 2026

  • 0 min

Share

Clinical Report: Modifying DeepLabV3+ for the Segmentation of Biopsy Lesions in Cervical Cancer

Overview

This study presents a novel approach using smartphone-assisted microscopy combined with DeepLabV3+ for the segmentation of cervical cancer lesions. The system achieved a mean Intersection over Union (IoU) of 75.8% and a Dice coefficient of 93.1%, demonstrating its potential in resource-constrained settings.

Background

Cervical cancer is a leading cause of cancer mortality, particularly in low and middle-income countries where access to advanced diagnostic tools is limited. Accurate histopathological analysis is crucial for effective diagnosis and treatment, yet many regions face significant barriers to such capabilities. This study addresses the urgent need for innovative, cost-effective solutions to improve diagnostic access in these underserved areas.

Data Highlights

MetricValue
Mean IoU75.8%
Dice Coefficient93.1%
Per-Class IoU Range74.13% - 75.41%
U-Net mIoU56.84%
U-Net Dice68.53%

Key Findings

  • The DeepLabV3+ model achieved a mean IoU of 75.8% on the validation set.
  • A Dice coefficient of 93.1% was recorded, indicating high segmentation accuracy.
  • Per-class IoU ranged from 74.13% to 75.41% across 21 histopathological feature classes.
  • DeepLabV3+ outperformed a U-Net baseline model under identical training conditions.
  • The approach integrates smartphone-assisted microscopy with advanced deep learning techniques.

Clinical Implications

The findings suggest that smartphone-assisted digital pathology can enhance diagnostic capabilities in resource-limited settings. Implementing such technology may improve early detection and treatment planning for cervical cancer, ultimately impacting patient outcomes positively.

Conclusion

This study demonstrates the feasibility of using DeepLabV3+ for effective segmentation of cervical cancer lesions in histopathological images, paving the way for improved diagnostic access in underserved regions. Further validation across multiple institutions is necessary to confirm these results.

Related Resources & Content

  1. European Radiology, 2022 -- Utilizing Deep Learning for Contrast-Enhanced CT Diagnosis of Cervical Lymph Node Metastasis in Oral Cancer: A Retrospective Analysis of 1466 Cases
  2. Gastric Cancer, 2025 -- Advancements in Deep Learning Techniques for the Pathological Assessment of Gastric Endoscopic Submucosal Dissection Samples
  3. European Radiology, 2023 -- Automated MRI Segmentation and Radiomic Feature Analysis of Hypopharyngeal Cancer Utilizing Deep Learning Techniques
  4. npj Digital Medicine, 2026 -- Enhanced Mamba Filtering Networks for Precise Segmentation of Hepatocellular Carcinoma Lesions in Abdominal CT Scans
  5. WHO, 2024 -- WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
  6. The ASCO Post, 2024 -- KEYNOTE-A18: Overall Survival in Cervical Cancer Improved by Pembrolizumab Plus Chemoradiotherapy
  7. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
  8. KEYNOTE-A18: Overall Survival in Cervical Cancer Improved by Pembrolizumab Plus Chemoradiotherapy - The ASCO Post

Original Source(s)

Related Content